Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QR052107B for subacute cough
CTR20231698Phase 2Completed
- Sponsor
- Wuhan Createrna Science and Technology Co., Ltd.
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of relicpixant, sponsored by Wuhan Createrna Science and Technology Co., Ltd.. Started Jun 2023; status: completed.
02
Drugs
relicpixant
Beyond the preview
Go deeper on CTR20231698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231698.